Hints and tips:
Related Special Reports
...GHO has also previously invested in Sterling Pharma Solutions, a specialist in the development of antibody drug conjugates, a new kind of cancer drug, and acquired Belgian contract manufacturer Ardena in...
...G42 has partnered with Sinopharm, the drugs company, and BGI, the genomics research group, in relationships that originated during the Covid-19 pandemic....
...Each zone will be focused around existing research institutions and industrial clusters, with up to £80mn of support — a mix of grants and tax breaks — available to help attract further jobs and private...
...In the UK, Wegovy is available in limited supply on the NHS but patients using private healthcare can pay up to £300 for a month’s supply. Costs are similar in Denmark and Germany....
...Rollout of Wegovy has been limited to the US, several European countries and the United Arab Emirates....
...In one example of an innovative approach to drug development, the Cystic Fibrosis Foundation used a “venture philanthropy” model to fund research and development of the drug ivacaftor....
...The Medicare programme is limited to wildly popular drugs that have already earned back their development costs many times over....
...Ten years ago, the Health Research Council of New Zealand began awarding funding along these lines....
...BMS argues much of the progress in the fight against cancer is the result of post-approval research on small molecule drugs for patients....
...First, there is limited understanding of the drug’s long-term impact and this will need to be closely monitored. Second, the drug will initially be expensive....
...For which aspects of the solution, approach or implementation were the lawyers responsible? How did you arrive at the specific approach or solution that was finally adopted?...
...Here, the cybernetic solution is to require private equity investors to guarantee the debts of takeover targets, sealing off the great accountability sink of limited liability....
...This also helps ensure academic research is transferred to society in the form of commercially viable products and services....
...and private purses....
...“There’s no reason why there shouldn’t be a private-label formula in the UK,” said Simpson. “My question would be — would parents buy it?”...
...of residential research at Savills....
...Chris Sykes, consultant at broker Private Finance, said the standard coverage was 145 per cent of the mortgage cost, “whereas it’s 125 per cent for properties held within a limited company, offering the...
...But if egg-freezing seemingly offers a possible solution to this demographic problem, it does so only for the lucky few....
...With advanced economies behind on their funding pledges too, market-based solutions offer a supplementary source of finance....
...If MHRA has its house in order, that’s of limited use if NICE, the body that approves drugs for use in the NHS, is still taking forever to do anything....
...Both are still trialling their new offerings for a limited number of clients. However, not everyone jumped in so fast....
...A working paper published in July by the National Bureau of Economic Research showed medical doctors in the US made an average of $350,000 a year....
...“It’s a big enough problem and enough people are working on it in parallel” to suggest that solutions will eventually be found, says Schwartz at Salesforce....
...But the ultimate solution, Gigerenzer added, was to reduce the pressure to publish, particularly in China....
International Edition